GlpBio

BI 2536

目录号: GC12450纯度: >98.00%同义词: BI-2536;BI2536
BI 2536是一种双重Polo样激酶（PLK）/溴结构域抑制剂，在无细胞激酶实验中，BI 2536 对PLK1、PLK2和PLK3的半数抑制浓度（IC50）值分别为0.83nM、3.5nM和9.0nM。
BI 2536
Cas No.: 755038-02-9
规格价格库存数量操作
5mg¥619.00现货
1
25mg¥1,050.00现货
1
50mg¥1,750.00现货
1
100mg¥3,150.00现货
1
10mM (in 1mL DMSO)¥711.00现货
1
电话: 400-920-5774Email: sales@glpbio.cn

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

BI 2536, dual Polo-like kinase (PLK)/bromodomain inhibitors, effectively reactivate latent HIV-1. Half maximal inhibitory concentration (IC50) values of BI 2536 against PLK1, PLK2, and PLK3 in cell-free kinase assays are 0.83nM, 3.5nM and 9.0nM, respectively[1].

In vitro, BI 2536 (0.1, 0.5, 1 and 2μM; 72h) inhibited the proliferation of ovarian cancer cells and induced cell cycle arrest at the G2/M phases[2]. BI 2536 (28.23 and 17.30nM; 24 and 48h) promotes neuroblastoma cell death via minichromosome maintenance complex components 2 and 10[3]. Alisertib cooperates with BI 2536 (14h and 24h) to induce cell cycle arrest and DNA double-strand breaks in small cell lung cancer[4]. BI 2536 (5nM and 10nM; 24h) induces apoptosis and attenuates the autophagic process in neuroblastoma cells[5].

In vivo, BI 2536 (10mg/kg/every other day; 20 days; i.p.) inhibited tumor growth in the cell-derived xenograft model mice[2]. Combining BI 2536 (10mg/kg; every other day for a total of five doses; i.v.) with alisertib impaired DNA repair capacity and significantly delayed tumor growth in mice[4].

References:
[1] Gohda J, Suzuki K, Liu K, et al. BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1. Sci Rep. 2018 Feb 23;8(1):3521.
[2] Huo J, Shen Y, Zhang Y, et al. BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer. Front Oncol. 2022 Aug 9;12:963928.
[3] Hsieh CH, Yeh HN, Huang CT, et al. BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10. Pharmaceuticals (Basel). 2021 Dec 28;15(1):37.
[4] Zhang J, Liu X, Hou P, et al. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer. Cell Death Dis. 2024 Jul 31;15(7):551.
[5] Li Z, Yang C, Li X, et al. The dual role of BI 2536, a small-molecule inhibitor that targets PLK1, in induction of apoptosis and attenuation of autophagy in neuroblastoma cells. J Cancer. 2020 Mar 5;11(11):3274-3287.

BI 2536是一种双重Polo样激酶（PLK）/溴结构域抑制剂，在无细胞激酶实验中，BI 2536 对PLK1、PLK2和PLK3的半数抑制浓度（IC50）值分别为0.83nM、3.5nM和9.0nM[1]。

在体外实验中，BI 2536（0.1, 0.5, 1和2μM; 72小时）抑制了卵巢癌细胞的增殖，并诱导细胞周期停滞在G2/M期[2]。BI-2536（28.23和17.30nM; 24和48小时）通过微染色体维持复合体组分2和10促进神经母细胞瘤细胞死亡[3]。阿利塞替布与BI 2536（14小时和24小时）协同作用，诱导小细胞肺癌细胞周期停滞和DNA双链断裂[4]。BI 2536（5nM和10nM; 24小时）诱导神经母细胞瘤细胞凋亡并减弱自噬过程[5]。

体内实验方面，BI 2536（10mg/kg/每隔一天; 20天; 腹腔注射）抑制了细胞来源的异种移植模型小鼠中的肿瘤生长[2]。将BI 2536（10mg/kg/每隔一天; 给药5次; 静脉注射）与阿利塞替布联合使用，可损害DNA修复能力，并显著延缓小鼠中肿瘤的生长[4]。

实验参考方法 Experimental Reference Method

Cell experiment [1]:

Cell lines

Human ovarian cell line A2780 cell

Preparation Method

Cells were seeded in a 12-well plate and treated with indicated drugs (DMSO, 0.1μM, 0.5μM, 1.0μM and 2.0μM BI 2536) for 72h. Then cells were washed with PBS, harvested, and fixed with anhydrous ethanol overnight. After washed with PBS, PI/RNase staining was added to suspend cells and incubate for 30min in dark. The cell cycle distribution was determined by flow cytometry.

Reaction Conditions

0.1μM, 0.5μM, 1.0μM and 2.0μM; 72h

Applications

BI 2536 inhibited the proliferation of ovarian cancer cells and induced cell cycle arrest at the G2/M phases.
Animal experiment [2]:

Animal models

Athymic nu/nu mice

Preparation Method

A total of 5 × 106 SCLC cells, suspended in a 100μL volume, were mixed with an equal volume of Matrigel and inoculated into the dorsal flank of a 4-6 week-old nu/nu mice. Once the tumors became palpable and measurable, mice were randomized into four groups and treated with either DMSO control, BI 2536 alone, alisertib alone, or a combination of BI 2536 and alisertib. BI 2536 (10mg/kg) was administered via tail vein injection every other day for a total of five doses. Alisertib (20mg/kg) was given orally every other day for a total of five doses. Each animal was tracked individually every other day for tumor growth by external caliper measurements of the protruding subcutaneous tumors. The tumor size was calculated using the following formula: Volume = (length × width2)/2.

Dosage form

10mg/kg; every other day for a total of five doses; i.v.

Applications

Combining BI 2536 with alisertib impaired DNA repair capacity and significantly delayed tumor growth in mice.

References:
[1] Huo J, Shen Y, Zhang Y, et al. BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer. Front Oncol. 2022 Aug 9;12:963928.
[2] Zhang J, Liu X, Hou P, et al. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer. Cell Death Dis. 2024 Jul 31;15(7):551.

产品文档 Product Documents

Purity:>98.00%

化学性质Chemical Properties

CAS 号
755038-02-9
同义词
BI-2536;BI2536
化学名
4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
SMILES
CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C
分子式
C28H39N7O3
分子量
521.67 g/mol
溶解性
≥ 13.04 mg/mL in DMSO, ≥ 92.4 mg/mL in EtOH with ultrasonic
保存条件
4°C, protect from light
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
为了提高溶解度，请将管子加热至 37°C，然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备 RT，或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol